Concepedia

Walter L. Johnson

WL

17

Publications

647

Citations

15

H-Index

1961

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Walter L. Johnson is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacotherapy, and drug discovery.

Top concepts

Publications per year

1961–2021

17

Publications

17

Discovery of a 2,4-Disubstituted Pyrrolo[1,2-<i>f</i>][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development

Mark D. Wittman, Joan M. Carboni, Yang Zheng et al. · Journal of Medicinal Chemistry · 2009 · 94 citations · Full text

Clozapine-Caused Eosinophilic Colitis

Jonathan W. Friedberg, Frances R. Frankenburg, Judy Burk et al. · Annals of Clinical Psychiatry · 1995 · 75 citations

, , +6

Automatic generation of efficient lexical processors using finite state techniques

Walter L. Johnson, James H. Porter, Stephanie I. Ackley et al. · Communications of the ACM · 1968 · 66 citations · Full text

RECORD LINKAGE IN MEDICINE

Walter L. Johnson · American Journal of Public Health and the Nations Health · 1969 · 66 citations

, , +9

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1

Andrew P. Degnan, Godwin Kumi, Christopher W. Allard et al. · ACS Medicinal Chemistry Letters · 2021 · 51 citations · Full text

Rows per page

1–5 of 17